Phase II study evaluating the combination of capecitabine and oxaliplatin in patients with gastric cancer
Phase of Trial: Phase II
Latest Information Update: 20 Nov 2015
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin
- Indications Gastric cancer
- Focus Therapeutic Use
- 20 Nov 2015 Results published in Chugai Pharmaceuticals media release.
- 20 Nov 2015 According to Chugai Pharmaceuticals media release, company announced that it has obtained supplemental approval from the Japanese Ministry of Health, Labour and Welfare (MHLW).
- 31 Jul 2015 New trial record